These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Cyclic AMP and cyclic AMP-dependent protein kinase in mouse skin. II. In vitro effects of isotretinoin and etretinate. Holian O, Kumar R. Arch Dermatol Res; 1985 Apr; 278(2):161-4. PubMed ID: 3006609 [Abstract] [Full Text] [Related]
32. [Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin]. Orfanos CE. Hautarzt; 1989 Mar; 40(3):123-9. PubMed ID: 2523875 [Abstract] [Full Text] [Related]
37. [Results of treatment of a number of disorders in the keratinization of the skin using an aromatic retinoid (Ro 10-9359)]. Notowicz A, Vermeiden I, Stolz E. Ned Tijdschr Geneeskd; 1980 Aug 02; 124(31):1286-90. PubMed ID: 7412901 [No Abstract] [Full Text] [Related]
38. [Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids]. Fontan B, Bonafé JL, Moatti JP. Ann Dermatol Venereol; 1983 Aug 02; 110(1):23-31. PubMed ID: 6859752 [Abstract] [Full Text] [Related]
39. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review. Brazzell RK, Colburn WA. J Am Acad Dermatol; 1982 Apr 02; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675 [Abstract] [Full Text] [Related]